Cargando…

Epithelial immune regulation of inflammatory airway diseases: Chronic rhinosinusitis with nasal polyps (CRSwNP)

Background: The epithelial immune regulation is an essential and protective feature of the barrier function of the mucous membranes of the airways. Damage to the epithelial barrier can result in chronic inflammatory diseases, such as chronic rhinosinusitis (CRS) or bronchial asthma. Thymic stromal l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klimek, Ludger, Hagemann, Jan, Welkoborsky, Hans-Jürgen, Cuevas, Mandy, Casper, Ingrid , Förster-Ruhrmann, Ulrike, Klimek, Felix, Hintschich, Constantin A., Huppertz, Tilman , Bergmann, Christoph, Tomazic, Peter-Valentin, Becker, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097524/ https://www.ncbi.nlm.nih.gov/pubmed/35572064 http://dx.doi.org/10.5414/ALX02296E

Ejemplares similares

Guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps (CRSwNP) in Brazil
por: Anselmo-Lima, Wilma T., et al.
Publicado: (2021)

Dokumentation von Biologika-Therapien bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP): Dupilumab, Omalizumab und Mepolizumab: Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)
por: Klimek, Ludger, et al.
Publicado: (2022)

Necroptosis Underlies Neutrophilic Inflammation Associated with the Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
por: Xie, Yadong, et al.
Publicado: (2021)

WITHDRAWN: Dupilumab: A review of potential in the treatment of Chronic rhinosinusitis with nasal polyps (CRSwNP)
por: Sree Sudha, T.Y., et al.
Publicado: (2020)

Cost–Utility Analysis of Dupilumab for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Italy
por: De Corso, Eugenio, et al.
Publicado: (2022)

Checklist for the Multidisciplinary Approach to United Airway in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and asthma
por: Castillo Vizuete, José Antonio, et al.
Publicado: (2022)

The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP)
por: Hardison, Scott A., et al.
Publicado: (2023)

Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP
por: Cantone, Elena, et al.
Publicado: (2022)

Computational fluid dynamic modeling of the effect of dupilumab in the management of anosmia secondary to chronic rhinosinusitis with nasal polyps (CRSwNP)
por: Lepley, Thomas J., et al.
Publicado: (2022)

EUFOREA consensus on biologics for CRSwNP with or without asthma
por: Fokkens, Wytske J., et al.
Publicado: (2019)

The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP
por: Campion, Nicholas J., et al.
Publicado: (2023)

Management of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in the Pan-Arab Region: Consensus Recommendations from a Multidisciplinary Expert Working Group
por: Marglani, Osama, et al.
Publicado: (2023)

Clinical characteristics of patients with CRSwNP with intensely high eosinophil level
por: Ma, Ling, et al.
Publicado: (2022)

Adverse events for biologics in patients with CRSwNP: A meta‐analysis
por: Shen, Yang, et al.
Publicado: (2022)

Profiling Disease and Economic Burden in CRSwNP Using Machine Learning
por: Bhattacharyya, Neil, et al.
Publicado: (2022)

Nasal cytology and histology in CRSwNP: Two sides of the same coin
por: Gelardi, Matteo, et al.
Publicado: (2023)

Differences in men and women suffering from CRSwNP and AERD in quality of life
por: Bartosik, Tina J., et al.
Publicado: (2020)

Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP
por: Bachert, Claus, et al.
Publicado: (2022)

Measuring Nasal Patency and the Sense of Smell in CRSwNP Patients Treated with Dupilumab
por: Ottaviano, Giancarlo, et al.
Publicado: (2023)

Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab
por: Ledda, Andrea Giovanni, et al.
Publicado: (2023)

Expression of Apoptosis-Related Biomarkers in Inflamed Nasal Sinus Epithelium of Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)—Evaluation at mRNA and miRNA Levels
por: Morawska-Kochman, Monika, et al.
Publicado: (2022)

Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab
por: De Schryver, Els, et al.
Publicado: (2015)

Real‐life effectiveness of biological therapies on symptoms in severe asthma with comorbid CRSwNP
por: Mümmler, Carlo, et al.
Publicado: (2021)

Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds
por: Chuang, Chien‐Chia, et al.
Publicado: (2021)

Effectiveness of Dupilumab in the Treatment of Adult and Older Adult Patients with Severe, Uncontrolled CRSwNP
por: Ottaviano, Giancarlo, et al.
Publicado: (2023)

Eosinophil-mast cell pattern of intraepithelial infiltration as a marker of severity in CRSwNP
por: Gelardi, Matteo, et al.
Publicado: (2023)

A Randomized Clinical Trial of Elemental Zinc Add-on Therapy on Clinical Outcomes of Patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
por: Akbari Dilmaghani, Nader, et al.
Publicado: (2019)

Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP
por: Minagawa, Shunsuke, et al.
Publicado: (2022)

Calprotectin in nasal secretion: a new biomarker of non-type 2 inflammation in CRSwNP
por: De Corso, Eugenio, et al.
Publicado: (2022)

Efficacy of Biologics on Refractory Eosinophilic Otitis Media Associated with Bronchial Asthma or Severe Uncontrolled CRSwNP
por: De Corso, Eugenio, et al.
Publicado: (2022)

How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review
por: De Corso, Eugenio, et al.
Publicado: (2023)

Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy
por: Albrecht, Tobias, et al.
Publicado: (2023)

Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab
por: Piazzetta, Giovanna Lucia, et al.
Publicado: (2023)

P123 Study of naïve and memory T helper cell response in patients of chronic rhinosinusitis with nasal polyposis (CRSwNP) after in vitro exposure to Aspergillus flavus
por: Das, Shukla, et al.
Publicado: (2022)

A retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men
por: Stevens, Whitney W, et al.
Publicado: (2015)

Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A “Real-Life” Observational Study in the First Year of Treatment
por: De Corso, Eugenio, et al.
Publicado: (2022)

Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients
por: Ottaviano, Giancarlo, et al.
Publicado: (2022)

Are objective ‘findings’ the same as subjective ‘severity’? A study of the relationship between computed tomography findings and subjective severity in preoperative CRSwNP patients
por: Lu, Hanyu, et al.
Publicado: (2020)

The efficacy and safety of several interventions of corticosteroids for CRSwNP patients after endoscope sinus surgery: A protocol for systematic review and network meta-analysis
por: Zhang, Lan, et al.
Publicado: (2022)

Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence
por: Mimmi, Selena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uofkskh006p9r71ritlaag50eb